Speakers

Pedro has gained extensive expertise in oncology translational research, becoming deeply passionate about precision and personalized medicine. This led him to join the Novartis Precision Medicine team in 2016, where he currently serves as Executive Director, Global Biomarker and Diagnostic Lead, leading Biomarker and diagnostic strategies for late-stage programs in Hematology and Oncology. Pedro has great expertise on diagnostic guidelines, patient selection and IVD development, and has witnessed first-hand the value that Precision medicine brings for the development of innovative solutions for patients.

At COCIR, the European association of manufacturers of radiological, radiotherapy and healthcare IT industry, Riccardo’s main focus is to help companies to navigate the complex EU legislation on chemicals and to work with EU institutions and national regulators to ensure that new legislative initiatives are proportionate and fit for the specific needs of the sector, supporting investment in R&D of new medical technologies and ensuring the availability of critical devices for patients.

Jacob is the CEO and co-founder of Njord Medtech. A medtech scale-up set on a mission to solve unmet needs in radiology and patient handling for sustainable healthcare. The company has been incubated in Sweden within the Sahlgrenska University Hospital since 2017 and incorporated in 2019. His earlier endeavours involve business development at Ericsson, Accenture, Luxbright, and The Techno Creatives.

She was Ambassador of Romania to Republic of Cyprus between 2006 and 2011 and to Israel, between 2013 and 2016. Previously, she held several positions in the Romanian Ministry for Foreign Affais. Thus, between 2001 and 2004, Mrs Păstîrnac was responsible for preparing the application and taking part in the negotiations for accepting Romania as a member in Task Force for International Cooperation on Holocaust Education, Remembrance and Research, and starting with 2002, until 2005, was responsible for preparing the participation of Romania in the Euro-Mediterranean Partnership.

Scientific coordinator of H2020 PCP project “NGS diagnostic in 21st century oncology: the best, for all, at all times”, involving 14 public and private partners from five European countries.

PATRIA group ranks among the foremost design-build organizations in the Country, and is continuing its expansion in the Region. Currently, he is leading multiple design projects in Croatia, Bosnia and Hercegovina and Kosovo, with the largest being the KBC Osijek (Clinical Hospital Center with an area of 255000 m2; investment 750 million euros) and Medikol Zagreb – Oncology Hospital marked as a strategic project by Republic of Croatia with an area of 70000 m2; investment 300 million euros